TianLong Science and Technology

Company Medical Device

Shanghai Kehua Bioengineering Subsidiary Receives Two IVD Certificates from NMPA

Fineline Cube Jul 23, 2025

China-based Shanghai Kehua Bioengineering Co., Ltd. (KHB) (SHE: 002022) announced on July 23, 2025, that...

Company Deals

TianLong Science and Technology Expands into Northern Thailand with Hepatitis Diagnostics

Fineline Cube May 26, 2023

Xi’an-based med-tech firm TianLong Science and Technology Co., Ltd has reportedly entered into a supply...

Company Drug

Zhifei Bio Initiates Phase I Study for DTaP-Hib Quadrivalent Vaccine – Component Combination Targets Pediatric Immunization Compliance

Company Drug

Changchun High-Tech Wins FDA Orphan Drug Designation for GenSci128 – TP53 Y220C Reactivator Targets Gastric Cancer

Policy / Regulatory

China NHC Elevates Chikungunya and SFTS to Category B Status – Enhanced Surveillance and Control Measures Effective April 2026

Company Drug

Gan & Lee’s Bonfaglutide Wins NMPA Approval for OSA Study – Biweekly GLP‑1 Expands to Sleep Apnea Indication